# Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/canagliflozin-primes-antitumor-immunity-by-triggering-pd-l1-degradation-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ling Ding,Xi Chen,Wenxin Zhang,Xiaoyang Dai,Hongjie Guo,Xiaohui Pan,Yanjun Xu,Jianguo Feng,Meng Yuan,Xiaomeng Gao,Jian Wang,Xiaqing Xu,Sicheng Li,Honghai Wu,Ji Cao,Qiaojun He,Bo Yang |
| Citations | 75 |
| DOI | 10.1172/jci154754 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.jci.org/articles/view/154754/files/pdf |
| OpenAlex ID | https://openalex.org/W4313427324 |
| PMID | 36594471 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Meng Yuan](https://scholariq.org/researchers/meng-yuan/)

## Paper primary topic

- [Adenosine and Purinergic Signaling](https://scholariq.org/topics/adenosine-and-purinergic-signaling/)

## Paper topics

- [Adenosine and Purinergic Signaling](https://scholariq.org/topics/adenosine-and-purinergic-signaling/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.